Document is current

Article History

Received: 3 December 2020

Accepted: 19 June 2021

First Online: 4 July 2021

Declarations

:

: Participating the neonatal screening parents give informed consent for registration of the results in Praeventis and the use for additional scientific research. A Praeventis working group evaluated our research protocol and provided the data. The Dutch neonatal heel prick (blot spot) screening program is part of the National Population Screening Programme in the Netherlands funded by the State and falls under the Dutch Population Screening Act. For our study no additional ethical approval was necessary, because neither extra specimens nor additional chemical analyses were required, in addition the provided dataset was anonymised, and consent for additional scientific research was provided. The data was provided by the working group management information of Praeventis. Praeventis is the registration system of the Dutch national vaccine provision and prevention program, which includes the neonatal screen.

: Not applicable.

: The author declare that she has no competing interests